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ABSTRACT 
Objectives: Vitamin E is an important human lipophilic antioxidant and is required for many metabolic functions. A 
high vitamin E intake appears to favorably impact a variety of disease processes. The vitamin E intake, excluding sup- 
plemental intake, of the vast majority of adults is below the current recommended level. By consuming vitamin 
E-enriched food, it is possible to take in adequate amounts of vitamin E. Vitamin E intake from enriched foods might 
prevent certain diseases without the need to ingest specific vitamin E supplements. The vitamin E that is present in en- 
riched foods has to exhibit maximal bioavailability to ensure a sufficient intake of vitamin E from one portion of forti- 
fied food. The aim of the present study was to develop an enriched food that has highly bioavailable vitamin E. Fur- 
thermore, we wanted to examine whether vitamin E bioavailability can be affected by the technological properties of 
fortified food. Methods: Volunteers were given test foods (cream cheese and mayonnaise) that had been fortified with 
60 mg of RRR-α-tocopherol. The test foods were technologically modified and the bioavailability of RRR-α-tocopherol 
was determined via a short-term kinetic measurement, which was 24 h long, and a long-term kinetic measurement, 
which was 28 d long. The test foods were characterized with respect to matrix properties. Results: In comparison to the 
mayonnaise group the serum α-tocopherol area under the curve (AUC) was significantly higher in the cream cheese 
group, as shown in the short-term kinetic (p = 0.010) and long-term kinetic (p = 0.017) studies. Conclusions: In con- 
clusion, RRR-α-tocopherol was more bioavailable in cream cheese than in mayonnaise in both short-term and long-term 
periods. Hence, food matrices affect bioavailability of RRR-α-tocopherol. Fortified foods with proven high α-toco- 
pherol bioavailabilities could be merchandised as functional foods with diseases prevention properties. 
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1. Introduction 
Vitamin E is a fat-soluble micronutrient that is required 
by humans for various metabolic functions. The most 
effective isomer of vitamin E is α-tocopherol, which is a 
naturally occurring lipophilic antioxidant. Vitamin E is 
present in cell membranes, wherein it defends against 
lipid peroxidation and prevents free radical generation. 
Vitamin E plays an important role in the pathophysiology 
of several conditions, including cardiovascular disease 
[1]. High vitamin E intake defends against a variety of 
disease processes, and vitamin E protects against dete- 
riorating immune function, provides neuroprotection, and 
has anti-inflammatory functions [2]. Nevertheless, data 
from the National Health and Nutrition Examination 
Survey (NHANES 1999-2000) indicate that the majority 
of the U.S. population does not meet the current dietary 
recommendation of 15 mg α-tocopherol/day [3]. The 
amount of vitamin E that is necessary to provide protec-  
tion from diseases cannot be gained by natural food alone. 
By consuming vitamin-E-enriched food it is possible to 
consume adequate amounts of vitamin E. Therefore, it is 
possible to prevent certain diseases without the need for 
ingesting vitamin E supplements. 
The absorption efficiency of vitamin E is between 15 
and 65% [4]. Several factors can influence the bioavail- 
ability of vitamin E, some are associated with the indi- 
vidual (age, lifestyle), whereas others relates to the food 
(matrix, amount of fat, amount consumed, chemical 
forms of the nutrient) [5]. Generally, vitamin E must be 
given with meals and not on an empty stomach in order 
to achieve maximum absorption [6]. The bioavailability 
of natural RRR-α-tocopherol is higher than that of syn- 
thetic all-rac-α-tocopherol [7]. Encapsulated vitamin E is 
poorly absorbed even when consumed with a meal. Vi- 
tamin E bioavailability can be enhanced by fortifying 
food with vitamin E [8]. The bioavailability of vitamin E 
is influenced by the amount of dietary fat and the matrix 
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of the food [9,10]. 
The aim of the present study was to develop vitamin 
E-enriched foods that ensure a high vitamin E bioavail- 
ability. Volunteers were given test foods that were forti- 
fied with α-tocopherol. α-tocopherol bioavailability was 
determined via a short-term kinetic study which was 24 h 
long, followed by a long-term kinetic study, which was 
28 d long. The test foods were characterized with respect 
to matrix properties. Furthermore, we examined whether 
α-tocopherol bioavailability is affected by the matrix 
properties of the test foods. 
Test food should be component of the subjects’ normal 
nutrition. Because of the liposolubility of vitamin E, it 
should be integrated into foods that have relatively high 
fat contents. We chose two different emulsions as test 
foods (cream cheese and mayonnaise) with different ma- 
trices and composition to evaluate whether the bioavail- 
ability differs among different matrices. Cream cheese is 
a disperse system with multiple phases that consist of a 
casein micelle network, dispersed fat droplets, and a cap- 
illary system wherein the remaining whey is immobilized. 
Cream cheese has a pH value of about 4.5. For the cream 
cheese that was tested in this study, an emulsion with a 
fat content of 60% (w/w) was prepared and mixed with 
curd instead of cream. 
Mayonnaise is a concentrated oil-in-water emulsion 
that has a fat content of 50% - 85% and a pH value of 3.8 
- 4.0. Mayonnaise interfaces are stabilized by the pro- 
tein-phospholipid complex of the egg yolk; however, 
these interfaces do not form a barrier that can prevent 
material transport processes. The continuous phase of the 
fat-reduced mayonnaise product contains water with the 
dissolved components, in addition to gelatinized starch, 
which forms a tri-dimensional network in the water 
phase and restricts barrier properties so as to permit mo- 
lecular diffusion [11]. 
2. Materials and Methods 
2.1. Subjects and Study Design 
The study protocol was approved by Freiburger Ethik- 
Komission International, Germany (07/2015). Written 
informed consent was obtained from all subjects in ac- 
cordance with the principles of the Helsinki Declaration. 
Healthy young subjects were recruited from the gen- 
eral population by notice. Smoking, the intake of dietary 
supplements with vitamin E, and diagnoses or suspicions 
of gastrointestinal disorders were defined as exclusion 
criteria. Inclusion and exclusion criteria were assessed 
via structured questionnaires before the intervention pe-
riod and on the intervention days. 
This study consisted of a short-term kinetic study and 
a long-term kinetic study. In each trial, subjects were 
asked to avoid foods that were rich in vitamin E to mini- 
mize intake variability. Restricted foods included vege- 
table oils, nuts, and cereals. 
In the short-term kinetic study, five male volunteers 
(mean age 30 ± 4 years) were given one of two test foods 
(cream cheese or mayonnaise), which had been fortified 
with 60 mg of RRR-α-tocopherol, in a randomized order 
with a crossover design, and each study day was sepa- 
rated by 7 d. On intervention days, each subject ingested 
a single portion of either cream cheese or mayonnaise 
after an overnight fast. The test food contained 5 g of fat 
and was given with a standard breakfast that contained 
30.1 g of fat, 29.6 g of protein, 67.9 g of carbohydrate, 
1.3 mg of vitamin E, and 2771 kJ of energy. Subjects 
consumed standard meals and beverages over 24 h. 
Blood samples were taken initially (pre-dose at baseline) 
as well as 1, 3, 5, 7, 9, 12, and 24 h after the intake of the 
test food.  
In the long-term kinetic study, subjects were randomly 
assigned to one of two treatment groups (each n = 9) and 
each took either one portion of either cream cheese or of 
mayonnaise that had been fortified with 60 mg of RRR- 
α-tocopherol daily for 28 d. Randomization was con- 
ducted according to gender. Fasting blood samples were 
taken pre-dose and weekly during the experimental period.  
2.2. Test Foods 
Both test foods (cream cheese and mayonnaise) were 
prepared by the German Institute of Food Technologies 
(Quakenbrück, Germany) in a laboratory scale using a 
two-stage process. First starch was gelatinized in the wa- 
ter phase using a universal kitchen machine (Thermomix, 
Vorwerk, Germany) for the mayonnaise preparation. 
Pre-emulsification was done with a stirrer, and the emul- 
sifying process was carried out again using the Thermo- 
mix. In order to make the cream cheese, curd was pre- 
pared according to the conventional production proce- 
dure (acid precipitation with cream cheese culture). Whey 
was removed from the curd by cutting the curd and sub-
sequently removing the separated whey. The final dry 
matter (DM) content was adjusted by centrifugation. The 
emulsion was prepared using the Thermomix. The curd 
and emulsion were mixed until a homogeneous distribu-
tion was reached. The formulations of the test foods are 
presented in Table 1. 
2.3. Anthropometric Measurements and Blood 
Sampling Foods 
Subjects were examined by trained professionals accord- 
ing to standardized methods at the Institute of Food Sci- 
ence and Human Nutrition of Leibniz University, Han- 
nover, Germany. Body weight was measured using a 
calibrated scale, body height was surveyed via tape 
measure, and body mass index (BMI) was calculated as 
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Table 1. Formulations of the test foods. 
mayonnaise cream cheese 
rapeseed oil 49.80% curd; 22.3% DMa 60.60%
water 37.65% water 32.14%
past. egg yolk 4.48% rapeseed oil 6.25%
Saccharose 2.49% Na-casein 0.47%
modified starch; E1422 2.59% NaCl 0.31%
NaCl 1.49% Xanthan 0.24%
vinegar; 5% acid 1.49%   
adry matter. 
 
weight (kg)/height (m)2. Blood samples were drawn us- 
ing serum monovettes (Sarstedt, Germany). All meas- 
urements (blood values and evaluation of anthropometric 
data) were carried out on every intervention day. 
2.4. Serum Analyses 
In order to collect serum, blood samples were allowed to 
coagulate for 20 min prior to centrifugation (2000 g, 10 
min, 10˚C). Serum samples were stored at 5˚C and 
shipped on ice to an accredited laboratory (Laborärz- 
tliche Arbeitsgemeinschaft für Diagnostik und Rational- 
isierung e.V., Hanover, Germany). α-tocopherol levels 
were measured by HPLC with UV-detection, and the 
results are expressed as µmol/L. Triacylglycerol (TG) 
and total cholesterol (TC) levels were enzymatically de- 
termined using automated standard laboratory methods 
(Olympus Life and Material Science Europa GmbH, 
Hamburg, Germany), and the results are expressed as 
µmol/L. 
2.5. Material Characterization 
The particle size distribution was determined by light 
scattering measurements using a Malvern Mastersizer X 
laser diffraction analyzer. A prerequisite for the laser 
diffraction spectroscopy is a low particle concentration; 
hence the emulsions were diluted to 1:20,000 in a tetra- 
sodium pyrophosphate solution. In this characterization 
technique, the light that is scattered by the droplets is 
detected as an angle-dependent intensity distribution. 
This diffraction pattern is converted into the volume dis-
tribution of the droplets using the mathematical back-
ground of Mie-theory. Based on the volume distribution 
the specific surface area (SSA) of the dispersed phase 
can be calculated. SSA is an integral value that describes 
the dispersed state of the emulsion. A further parameter 
is Xn which describes the percentage volume (n) that is 
occupied by particles with a diameter that are less than a 
determined value. This parameter was used to calculate 
the average diameter and size dispersion coefficient (δ), 
which is defined as δ = (D90 – D10)/D50. 
The extractable fat content (EFC) was measured ac- 
cording to a method described by Kielmeyer and Schus- 
ter [12]. The intensities of material exchange processes in 
dispersed multiphase systems considerably depend on the 
state of the interfaces. Using this method, the quantity of 
fat that can be extracted from the dispersed phase by a 
non-polar solvent is determined. EFC values decreases 
with a higher density and stability of the interface. 
2.6. Mathematical and Statistical Analyses 
Data are presented as the mean ± standard deviation (SD) 
for continuous variables, and the number of subjects (n) 
and percentage (%), respectively, for categorical vari- 
ables. The serum α-tocopherol concentrations were ad- 
justed to TC and TG levels. All serum levels were cor- 
rected to baseline levels (t0). The areas under the curve 
(AUC) of α-tocopherol and adjusted α-tocopherol values 
were calculated for each person for each study day ac- 
cording to the trapezoidal rule. The time-to-maximum 
concentration (tmax) and maximal concentrations (cmax) 
were identified by visual inspection of the data. Data 
were found to be normally distributed using the Kolmo- 
gorov-Smirnov test, and therefore parametric tests were 
used for the statistical analyses. An independent sample 
t-test was used to reveal significant differences between 
the two intervention groups. All tests were two sided and 
a p ≤ 0.05 was considered to be statistically significant. 
SPSS software (version 16.0; SPSS Inc, Chicago, IL, 
USA) was used for all of the statistical analyses. 
3. Results 
3.1. Short-Term Kinetic Study 
Five healthy males participated in the short-term kinetic 
study. Their mean age was 30 ± 4 years, mean height was 
1.80 ± 0.07 m, mean weight was 79.3 ± 8.1 kg, and mean 
BMI was 24.6 ± 3.0 kg/m2. Due to the crossover study 
design, baseline levels were not significantly different 
between the treatment groups. 
The maximum concentration of α-tocopherol was not 
significantly different in both treatments groups. tmax was 
significantly higher in the mayonnaise group than that in 
the cream cheese group. There were no significant dif-
ferences between the two treatment groups in serum 
α-tocopherol AUC0-24 levels or adjusted α-tocopherol/TC 
AUC0-24 values; however, the adjusted α-tocopherol/TC + 
TG AUC0-24 levels were significantly higher (p = 0.010) 
in subjects after ingestion of cream cheese in comparison 
to those after the ingestion of mayonnaise. The pharma- 
cokinetic levels of the short-term kinetic study are shown 
in Table 2 and Figure 1. 
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3.2. Long-Term Kinetic Study 
The characteristics of the long-term kinetic study popula- 
tion are presented in Table 3. No significant absolute 
differences in sexes or anthropometric variables were 
found between the two treatment groups. 
There were no significant differences in the maximum 
concentration of α-tocopherol or tmax following ingestion 
of cream cheese vs. mayonnaise. Likewise, the α-toco- 
pherol AUC0-4 values were similar after cream cheese 
and mayonnaise consumption. The adjusted AUC0-4 lev-
els were significantly higher [p = 0.018 for AUC0-4 
(α-tocopherol/TC) and p = 0.017 for AUC0-4 (α-toco- 
pherol/TC+TG)] after the ingestion of cream cheese vs. 
those after ingestion of mayonnaise. 
The pharmacokinetic levels of the long-term kinetic 
study are summarized in Table 4 and Figure 2. 
3.3. Test Food 
The size distribution of the emulsion droplets was almost 
equal in the cream cheese and the mayonnaise, as was the 
boundary layer. The dispersion coefficient was nearly the 
same in both test foods as well (Table 5). 
The EFC differed considerably between the two emul- 
sions. The EFC of mayonnaise was about 16 times great-
er than that of cream cheese (Table 6). 
4. Discussion 
This study was designed to determine whether vitamin E 
from fortified cream cheese and mayonnaise is bioavail- 
able when the fortified foods are consumed. A second 
aim of this study was to examine if the vitamin E bio-
availability is affected by the technological properties of 
the fortified food. The results demonstrate that vitamin E 
is bioavailable from fortified cream cheese and may- 
onnaise. The bioavailability of α-tocopherol was signifi- 
cantly greater in fortified cream cheese in comparison to 
fortified mayonnaise at 24 h and at 28 d. Furthermore the 
time to reach the maximum serum concentration of 
 
Table 2. Serum maximal concentration (cmax) and area 
under curve (AUC0-24)-α-tocopherol concentrations cor- 
rected to the baseline level and time-to-maximum con- 
centration (tmax) in the cream cheese and the mayonnaise 
group of the short-term kinetic study, means ± SD. 
 cream cheese mayonnaise pa 
cmax [µmol/l] 3.9 ± 2.0 3.9 ± 2.7 0.999
tmax [h] 5.4 ± 1.7 7.4 ± 0.9 0.046
AUC0-24 (α-tocopherol) 
[µmol*h/l] 57.3 ± 43.2 55.2 ± 35.2 0.934
AUC0-24  
(α-tocopherol/TCb) 
[µmol*h/l] 
0.016 ± 0.004 0.011 ± 0.004 0.089
AUC0-24  
(α-tocopherol/TCb+TGc)
[µmol*h/l] 
0.011 ± 0.004 0.002 ± 0.005 0.010
at-test for independent variables (cream cheese vs. mayonnaise). btotal cho-
lesterol. ctriacylglyceride. 
 
 
Figure 1. Mean serum α-tocopherol/total cholesterol (TC) + triacylglyceride (TG) concentration corrected to the baseline 
level vs. time profiles after consumption of either cream cheese (▲) or mayonnaise (□) fortified with 60 mg α-tocopherol of 
the short-term kinetic study, n = 5 . 
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 α-tocopherol was shorter in the cream cheese group than 
the mayonnaise group, indicating that α-tocopherol was 
absorbed faster from the cream cheese. In addition, a 
relationship between the particle size of the emulsion and 
the bioavailability of α-tocopherol was shown.  
Short-term kinetics were measured by a crossover 
study, which demonstrated that the differences in α-to- 
copherol bioavailability between mayonnaise and cream 
cheese are primarily caused by food matrix variation. 
The matrices of the administered test foods are charac- 
terized by the formulation and physical stabilization of 
the emulsions, both of which strongly depend on the in- 
terfacial properties of the proteins that assemble the in- 
terfaces. The ability of proteins to stabilize oil droplets in 
emulsions is influenced by their structure and conforma- 
tion [13]. Proteins are adsorbed at the interfaces because 
of their amphiphilic properties. Interfacial properties are 
influenced by adsorbed amount, surface tension, network 
formation, and the possible conformational changes of 
proteins during and after adsorption [14]. The interfaces 
in mayonnaise are stabilized by the protein-phosphol-  
 
Table 3. Characteristics of the study population of the long- 
term kinetic study, means ± SD.  
 cream cheese (n = 9) 
mayonnaise 
(n = 9) p
a 
Age [y] 28.3 ± 4.0 26.1 ± 4.6 0.287
Height [m] 1.75 ± 0.06 77.2 ± 11.2 0.346
Weight t0 [kg] 70.2 ± 13.7 24.3 ± 4.0 0.255
BMIb t0 [kg/m2] 22.8 ± 3.4 1.79 ± 0.08 0.382
at-test for independent variables (cream cheese vs. mayonnaise). bbody mass 
index. 
Table 4. Serum maximal concentration (cmax) and area 
under curve (AUC0-24)-α-tocopherol concentrations cor- 
rected to the baseline level and time-to-maximum con- 
centration (tmax) in the cream cheese and the mayonnaise 
group of the long-term kinetic study, means ± SD. 
 cream cheese mayonnaise pa
cmax [µmol/l] 9.33 ± 3.79 8.33 ± 4.41 0.612
tmax[h] 1.6 ± 0.7 1.2 ± 0.4 0.286b
AUC0-24 (α-tocopherol)  
[µmol*h/l] 20.6 ± 11.8 18.8 ± 8.0 0.709
AUC0-24 (α-tocopherol/TCc) 
[µmol*h/l] 0.007 ± 0.003 0.004 ± 0.002 0.018
AUC0-24 (α-tocopherol/TCc+TGd)
[µmol*h/l] 0.004 ± 0.001 0.002 ± 0.001 0.017
at-test for independent variables (cream cheese vs. mayonnaise); bMann- 
Whitney-Test; ctotal cholesterol; dtriacylglyceride. 
 
Table 5. Droplet size distributions (D), specific surface area 
(SSA) and dispersion coefficient (δ) of test foods (cream 
cheese and mayonnaise) measured with a Malvern Master- 
sizer X.  
test food D10 [µm] D50 [µm] D90 [µm] δ SSA [m2/g]
cream cheese 1.08 5.89 13.53 2.11 2.21 
mayonnaise 1.42 4.32 11.58 2.35 2.14 
 
Table 6. Extractable fat content (EFC) of test foods (cream 
cheese and mayonnaise). 
test food EFC [g/100 g fat] 
cream cheese 0.58 ± 0.03 
mayonnaise 9.50 ± 0.21 
 
 
 
Figure 2. Mean serum α-tocopherol/total cholesterol (TC) + triacylglyceride (TG) concentration corrected to the baseline level 
vs. time profiles after consumption of either cream cheese (▲) or mayonnaise (□) fortified with 60 mg α-tocopherol of the 
short-term kinetic study, n = 5 . 
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ipid-complex of the egg yolk, whereas the boundary layer 
in cream cheese is formed by casein; however, the inter- 
face in mayonnaise seems to form a more unstable bar- 
rier in comparison to the cream cheese interface and is 
not able to prevent material transport processes [15]. For 
this reason, a higher absorption of α-tocopherol was ex- 
pected after mayonnaise consumption; however, our data 
indicate a higher α-tocopherol bioavailability following 
the consumption of cream cheese. This unexpected result 
could be due to the salt that was used in the mayonnaise. 
The use of salt leads to a reduced energy barrier, which 
permits proteins to intrude into the network. The surface 
charge of the proteins is saturated by salt ions, such that 
the electric repulsion from proteins with identical charges 
is reduced. This leads to a very strong network and a 
stabilized mayonnaise emulsion [16]. Moreover, the dis- 
perse oil droplets are close packed, such that van der 
Waals forces further increase stability [17]. In summary, 
the interfaces of mayonnaise were stable to the point that 
α-tocopherol absorption out of the oil droplets could have 
been impeded. 
Cream cheese is a dispersed system with multiple 
phases consisting of a casein micelle network, dispersed 
fat droplets, and a capillary system wherein the remain- 
ing whey is immobilized. Casein forms chain-like struc- 
tures that are connected with van der Waals forces, 
which lead to a robust and compact gel. Oil was added to 
the cream cheese to enhance the creamy characteristic. 
The oil droplets integrate into the casein micelle network 
and cause destabilization [18]. 
In addition to the compounds in the interface, the pH 
value of the food matrix can affect the absorption of 
α-tocopherol. The secretion of the gastrointestinal hor- 
mone cholecystokinin is induced by duodenal chymus 
with pH value of approximately 4.0 - 4.5. The release of 
cholecystokinin initiates the secretion of pancreatic en- 
zymes for lipid digestion [19,20]. A test food with pH 
value in the range of the physiological intestinal pH val-
ue will lead to a release of cholecystokinin, and the re-
lease of cholecystokinin leads to a higher absorption of 
lipids and lipophilic α-tocopherol. The pH value of 
mayonnaise is about 3.8 - 4.0, whereas cream cheese has 
a pH value of about 4.5; hence, the bioavailability of 
α-tocopherol from cream cheese should be larger than 
that of mayonnaise because the pH value of cream cheese 
is in the range of the physiological pH value of 4.0 - 4.5 
[11]. 
In addition to the compounds in the interface and the 
pH value of the food matrix, the total emulsifier content 
impacts the stability of the boundary layer and, by exten- 
sion, the emulsion. Interfaces stability correlates with 
α-tocopherol bioavailability. Robust interfaces make it 
harder for digestive enzymes to get across the interface 
into the oil droplets to absorb the α-tocopherol. The 
mayonnaise contained slightly more emulsifiers than the 
cream cheese. The mayonnaise contained 4.48% egg yolk 
and 2.59% modified starch, whereas the cream cheese 
contained 7.39% whey protein from curd (6.21% casein) 
and additional 0.47% casein. Therefore, the bioavailabi- 
lity of α-tocopherol should be greater in the cream cheese 
because it is less stable than the mayonnaise.  
In summary, cream cheese seems to possess matrix 
characteristics that provide higher α-tocopherol absorp- 
tion, whereas the emulsion of mayonnaise seems to be 
more consistent with better digestion. 
Increases in α-tocopherol serum levels are limited. The 
α-tocopherol values rose within the first week of investi- 
gation but remained stable thereafter. This saturation is 
due to an initially limited quantity of hepatic α-toco- 
pherol transfer protein (α-TTP). An increased expression 
of α-TTP can be induced by dietary α-tocopherol [21]. 
α-TTP serum levels increase until there is a complete 
occupation of the α-TTP and decrease slightly thereafter 
because of an elevated hepatic α-tocopherol metabolism 
[22]. The higher daily absorption of α-tocopherol from 
cream cheese, in comparison to that of mayonnaise, leads 
to an increased expression of α-TTP following the con- 
sumption of cream cheese. This finding was verified by a 
long-term kinetic study that indicates that the chronic 
administration of α-tocopherol results in a steady serum 
level that occurred after 4 - 5 d of supplementation [23]. 
A physical characterization of the test foods was con- 
ducted to determine the potential bioavailability of 
α-tocopherol. To our knowledge, this is the first study to 
evaluate whether α-tocopherol bioavailability can be af- 
fected by the material properties of fortified food. These 
data suggest that size distributions of the emulsions 
droplets, as well as the expanse of the boundary layer, 
can be used as measures of α-tocopherol bioavailability. 
A larger expanse of boundary layers causes a larger sur- 
face for digestive enzymes to absorb α-tocopherol from 
fortified test foods. The size distribution of the emulsion 
droplets and the boundary layer did not differ between 
the cream cheese and the mayonnaise. Based on these 
data cream cheese and mayonnaise was expected to have 
equal α-tocopherol bioavailabilities; however, our data 
indicate a higher α-tocopherol bioavailability following 
the intake of cream cheese. EFC values can describe the 
permeability of the interface, and, therein the stability of 
the emulsion. These data can even be an indicator for the 
accessibility of the dispersed fat droplets to digestive 
enzymes. The two emulsions had very different EFC 
values. The extractable fat of the mayonnaise was about 
16 times greater than that of cream cheese. The EFC 
value may relate to the amount of α-tocopherol that can 
be absorbed from the test food. Nevertheless, our data 
show a significantly higher α-tocopherol bioavailability 
following the consumption of cream cheese. Conse- 
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quently, no correlation was found between the EFC and 
α-tocopherol bioavailability. 
In summary, these results indicate that the bioavail- 
ability of α-tocopherol of fortified cream cheese was sig- 
nificantly higher than that of fortified mayonnaise, over 
both short-term and long-term period. The bioavailability 
of α-tocopherol from fortified oil-in-water emulsions is 
influenced by interface properties. A technological char- 
acterization of the test foods has shown that particle size 
and boundary layer positively correlate with α-tocopherol 
bioavailability; however, there is no relationship between 
the amount of extractable fat and the bioavailability of 
α-tocopherol. In conclusion, fortified food with high 
α-tocopherol bioavailabilities could be used to help peo- 
ple ingest adequate amounts of vitamin E. Fortified foods 
with proven high α-tocopherol bioavailabilities could be 
merchandised as functional foods with disease preven- 
tion properties. Nevertheless, these results should be va-
lidated with additional kinetic studies. Future studies 
should be conducted with a variety of test foods with on 
oil-in-water emulsions, and there should be a detailed 
characterization of the technological properties of the 
food matrices. 
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